Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Patent
1995-01-20
1996-01-16
Phelan, D. Gabrielle
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
424434, 424435, 424441, 424484, A61K 968
Patent
active
054846021
ABSTRACT:
The present invention is directed to methods and compositions for noninvasively administering drugs in a dose-to-effect manner to produce a cardiovascular or renal vascular activity. A cardiovascular or renal vascular drug, which is capable of absorption through mucosal tissues of the mouth, pharnyx, and esophagus is incorporated into a matrix which is in the form of a lollipop. A patient is put at ease when given the lollipop, and the drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and remove the lollipop when it has had a desired effect on the patient. A lollipop into which a cardiovascular or renal vascular drug has been dispersed is particularly useful for achieving rapid vasodilating, calcium channel blocking, beta-blocking, seritonin receptor blocking, angina blocking, antihypertensive, and cardiac stimulating effects and for controlling urine output.
REFERENCES:
patent: D93287 (1934-09-01), Reed
patent: 109677 (1870-11-01), Seitz
patent: D117455 (1939-11-01), Parr
patent: D117456 (1939-11-01), Parr
patent: 122507 (1872-01-01), Wills
patent: 1430642 (1922-10-01), Gross
patent: 1593858 (1926-07-01), Venable
patent: 1847415 (1932-03-01), Snell
patent: 1915614 (1933-06-01), Parker
patent: 1971560 (1934-08-01), Guyon
patent: 2096611 (1937-10-01), Ellestad
patent: 2208120 (1940-07-01), Coleman
patent: 2246778 (1941-06-01), Cahoon
patent: 2295042 (1942-09-01), Llewellyn
patent: 2323656 (1942-07-01), Helfenstein
patent: 2388533 (1945-11-01), Edmondson et al.
patent: 2469589 (1949-05-01), Barricini
patent: 2488272 (1949-11-01), Davis
patent: 2499734 (1950-03-01), Edmondson et al.
patent: 2508560 (1950-05-01), Adams
patent: 2553446 (1951-05-01), Edmondson et al.
patent: 2857908 (1958-10-01), Cornfield
patent: 2897624 (1959-08-01), Yakel et al.
patent: 2915061 (1959-12-01), Edmondson et al.
patent: 2926121 (1960-02-01), Hobbs et al.
patent: 2963404 (1960-12-01), Hammer et al.
patent: 3114642 (1963-12-01), Meisel
patent: 3169907 (1965-02-01), Heusser et al.
patent: 3172179 (1965-03-01), Schafer
patent: 3192924 (1965-07-01), Edmondson et al.
patent: 3210247 (1965-10-01), Suranyi
patent: 3264115 (1966-08-01), Davis
patent: 3271256 (1966-09-01), Frey
patent: 3341414 (1967-09-01), Cherkas et al.
patent: 3344030 (1967-09-01), Stevens et al.
patent: 3399673 (1968-09-01), Jones et al.
patent: 3418743 (1968-12-01), Halvorsen
patent: 3429308 (1969-02-01), Russell
patent: 3438787 (1969-04-01), DuRoss
patent: 3444858 (1969-05-01), Russell
patent: 3493652 (1970-02-01), Hartman
patent: 3556811 (1971-01-01), Smith
patent: 3622352 (1971-11-01), Daylor, Jr.
patent: 3697641 (1972-10-01), Ahrens
patent: 3738845 (1973-01-01), Liebrand
patent: 3797494 (1974-03-01), Zaffaroni
patent: 3816953 (1974-06-01), Hameen-Anttila
patent: 3867927 (1975-02-01), Hergott
patent: 3907811 (1975-09-01), Janssen et al.
patent: 3907813 (1975-09-01), Janssen et al.
patent: 3943928 (1976-03-01), Lariccia et al.
patent: 3966940 (1976-06-01), Pachter et al.
patent: 3993762 (1976-11-01), Langbein et al.
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4053604 (1977-10-01), Jaramillo
patent: 4060084 (1977-11-01), Chandrasekaran et al.
patent: 4093709 (1978-06-01), Choi et al.
patent: 4131648 (1978-12-01), Choi et al.
patent: 4138344 (1979-02-01), Choi et al.
patent: 4139627 (1979-02-01), Lane et al.
patent: 4168308 (1979-09-01), Wretlind et al.
patent: 4169885 (1979-10-01), Raaf et al.
patent: 4225627 (1980-09-01), Moore
patent: 4226848 (1980-10-01), Nagai et al.
patent: 4229447 (1980-10-01), Porter
patent: 4241092 (1980-12-01), Halik et al.
patent: 4292299 (1981-09-01), Suzuki et al.
patent: 4307075 (1981-12-01), Martin
patent: 4311722 (1982-01-01), Vink et al.
patent: 4346709 (1982-08-01), Schmitt
patent: 4366159 (1982-12-01), Magruder
patent: 4369172 (1983-01-01), Schor et al.
patent: 4372942 (1983-02-01), Cimiluca
patent: 4389393 (1983-06-01), Schor et al.
patent: 4390520 (1983-06-01), Nagai et al.
patent: 4452825 (1984-06-01), Klacik et al.
patent: 4466953 (1984-08-01), Keith et al.
patent: 4470962 (1984-09-01), Keith et al.
patent: 4482534 (1984-11-01), Blank
patent: 4485087 (1984-11-01), Otsuka et al.
patent: 4515769 (1985-05-01), Merritt
patent: 4517173 (1985-05-01), Kizawa et al.
patent: 4529589 (1985-07-01), Davydov et al.
patent: 4551329 (1985-11-01), Harris et al.
patent: 4572832 (1986-02-01), Kigasawa et al.
patent: 4588580 (1986-05-01), Gale et al.
patent: 4599342 (1986-07-01), LaHann
patent: 4642231 (1987-02-01), Peters et al.
patent: 4668523 (1987-05-01), Begleiter
patent: 4671953 (1987-06-01), Stanley et al.
patent: 4692339 (1987-09-01), Stetson et al.
patent: 4695463 (1987-09-01), Yang et al.
patent: 4749575 (1988-01-01), Rotman
patent: 4753800 (1988-01-01), Mozda
patent: 4755386 (1988-07-01), Hsiao et al.
patent: 4764378 (1988-08-01), Keith
patent: 4847090 (1989-07-01), Della Posta et al.
patent: 4863737 (1989-09-01), Stanley et al.
patent: 4885173 (1989-12-01), Stanley et al.
Dyer, "Medicated Candies" 1 Q.S. 4 (1953).
Brown, "Absorption of Analgesics from the Buccal Mucous Membrane," 196, The Practitioner 125 (1966).
Beckett et al., "Buccal Absorption of Basic Drugs and its Application as an In Vivo Model of Passive Drug Transfer Through Lipid Membranes," 19 J. Pharm. Pharmac. 31S (1967).
Dearden et al., "Buccal Absorption as a Parameter of Analgesic Activity of Some P-substituted Acetanilides," 23 Journal Pharm, Pharmac. 73S (1971).
Dearden et al., "A New Bucaal Absorption Model," 23 J. Pharm. Pharmac. 68S (1971).
Dollery et al., "Differences in the Metabolism of Drugs Depending Upon Their Routes of Administration," 179 Annals of the New York Academy of Sciences 108 (1971).
Dobkin, "Buprenorphine Hydrochloride: Determination of Analgesic Potency," 24 Canadian Anesthesiology Society Journal 186 (1977).
Kirk-Othmer, 4 Encyclopedia of Chemical Technology 3d Ed., pp. 914-925 (1978).
Edge et al., "Analgesic Effects of Sublingual Buprenorphine," 34 Anaesthesia 463 (1979).
Fry, "Relief of Pain After Surgery," 34 Anaesthesia 549 (1979).
Braunwald, "Introduction: Calcium Channel Blockers," 46 The American Journal of Cardiology, pp. 1045-1045 (Dec. 1980).
Antman et al., "Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders, Part I and Part II," 93 Annals of Internal Medicine, pp. 875-900 (1980).
Bullingham et al., "Sublingual Buprenorphine Used Postoperatively: Clinical Observations and Preliminary Pharmocokinetic Analysis," 12 Br. J. Clin. Pharmac. 117 (1981).
Hug et al., "The Pharmacokinetics of Fentanyl," Janssen Pharmaceutica, Inc. (1981).
Ellis et al., "Pain Relief After Abdominal Surgery-A Comparison of I. M. Morphine, Sublingual Buprenorphine and Self-Administrated I.V. Pethidine," 54 Br. J. Anaesth. 421 (1982).
Port et al., "Carfentanil: The Primate Experience," American College of Veterinary Anesthesiolgiests (1983).
Port et al., "Topical Narcotic Anesthesia," 59 Anesthesiology (1983).
Abrams, "New Nitrate Delivery Systems: Buccal Nitroglycerin," vol. 105 American Heart Journal, pp. 848-854 (May 1993).
Windholz et al., "The Merck Index," published by Merck & Co., Inc. pp. 575, 795, 796 and Appendix 3 (1983).
Eleven articles from The First North American Nitroglycerin Symposium, The American Journal of Medicine (Jun. 27, 1983).
White et al., "Comparative Pharmacology of Intravenous Anesthetics-A Model for Determining Dosage Requirements and Therapeutic Concentration Ranges During Surgery," 59 Anesthesiology, A379 (Sep. 1983).
Stanley et al., "The Effect of Population Habits on Side Effects and Narcotic Requirements During High-Dose Fentanyl Anaesthesia," 31 Can Anaesth. Soc. J. 398 (1984).
Derbyshire et al., "Non-Parenteral Postoperative Analgesia," Anesthesia 39, pp. 324-328 (1984).
Border, "Recent Advances in Beta-blocker Therapy for Hypertension," vol. 19 Hosp. Formul. pp. 1120-1126 (Dec. 1984).
DeBoer et al., "Drug Absorption by Sublingual and Rectal Routes," 56 British Journal of Anaesthesiology 69 (1984).
Asthana et al., "Verapamil Disposition and Effect on PQ-Intervals After Bu
Hague Brian
Stanley Theodore H.
Phelan D. Gabrielle
University of Utah Research Foundation
LandOfFree
Methods and compositions for noninvasive dose-to-effect administ does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for noninvasive dose-to-effect administ, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for noninvasive dose-to-effect administ will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307919